Management of CNS and VAP Infections with a New Ready to use Combination: A Retrospective Study

Journal Title: International Journal of Contemporary Medical Research - Year 2017, Vol 4, Issue 4

Abstract

Introduction: The present retrospective study was aimed to analyze the efficacy of ready to use combination (RTUC) of (ceftriaxone + vancomycin) along with metronidazole compared to other drug combinations for management of ICU patients suffering from post-operative central nervous system (POCNS) and ventilator associated pneumonia (VAP) infections due to multi-drug resistant (MDR) gram-positive bacteria. Material and Methods: This study analyzed the data of 208 patients treated at a tertiary-care hospital. Patient demographic characteristics, infection type, co-morbidities, antibiotic therapy, dosage, treatment duration have been studied. Microbiological success was measured in terms of bacterial eradication, while clinical success was monitored in terms of complete omission of systemic signs and symptoms. Results: Among 208 patients analyzed, 150 cases were found to be suffering from POCNS infections and 58 patients were of VAP. Out of these 208 patients, 79 cases were treated with empirical use of Meropenem-Vancomycin (MER-VAN), 55 cases were treated with empirical use of Piperacillin Tazobactam-Tigecycline (PTZTIG) and the remaining 74 cases were treated with empirical use of Ready to Use Combination of Vancomycin and Ceftriaxone along with Metronidazole (RTUC-Metro). The clinical cure rates reported in MER-VAN, PTZ-TIG and RTUC-Metro groups were 77.2%, 72.7%, and 81.1% respectively. Conclusion: Infections with MDR gram-positive bacteria are frequent in ICU patients and the current study demonstrates that RTUC in combination with metronidazole has comparatively equivalent efficacy to MER-VAN and better than PTZ-TIG combinations. The results of this retrospective study favors the use of RTUC as a safer alternative to any other available drugs to treat ICU patients with infections caused due to MDR gram-positive bacteria. However more data from other centers on different indications needs to collected in favor of this new combination.

Authors and Affiliations

Obaid Ahmad Siddiqui, Lubna Zafar, Mohammad Amin Mir

Keywords

Related Articles

Systemic Inflammatory Markers as Predictor of Severity of Chronic Obstructive Pulmonary Disease (COPD) A Case - Control Study

Introduction: COPD is a systemic inflammatory disorder in which systemic inflammation contributes to the various systemic effects of the disease. The disease is associated with low-grade systemic inflammation which is mu...

Triple Malignancy Involving Breast, Ovary and Uterine Vault: A Case Report and Literature Review

Introduction: The occurrence of two or more primary malignant neoplasms in the same person is rare. We have a case report of a 45-year-old woman with triple malignancy involving breast, ovary and uterine vault being mana...

Role of Microlaryngobronchoscopy in Pediatric Airway Obstruction

Introduction: Respiratory distress due to airway obstruction is a common emergency seen in children. The aim of this study was to study the clinical profile of airway obstruction in pediatric age group and to identify th...

Salivary Amylase as a Biomarker in Health and Periodontal Diseases

Introduction: Amylase is a key protein secreted in the saliva as a part of oral host immune response in periodontal disease. To detect its level according to the severity of periodontal disease, the present study was con...

Immunohistochemical Staining by TTF-1 and P63 Markers for Typing of Non Small Cell Lung Carcinomas: A Three Year Study of A Tertiary Care Health Centre

Introduction: Studies have shown that selection of therapies such as vascular endothelial growth receptor (VEGR) and epithelial growth factor receptor (EGFR) inhibitors may depend on the correct differentiation of squamo...

Download PDF file
  • EP ID EP429073
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Obaid Ahmad Siddiqui, Lubna Zafar, Mohammad Amin Mir (2017). Management of CNS and VAP Infections with a New Ready to use Combination: A Retrospective Study. International Journal of Contemporary Medical Research, 4(4), 903-909. https://europub.co.uk/articles/-A-429073